During the opening segment of this program, part of the Oncology Stakeholder Summit, Spring 2015 series, program moderator Bruce Feinberg, DO, asks managed care stakeholders to provide their insight about the role, impact, and future of patient-centered care in oncology.
When asked about the concept of patient-centered medicine, Brian Kiss, MD, explains that the term “patient-centered” can be overused and thus lose its meaning. Dr Kiss defines patient-centered care as a model that looks at the patient and creates a care system that meets the patient’s needs, rather than a model that fits the patient into an established care system. He adds that identifying the real needs of each patient is an important part of the patient-centered care model.
Scott Gottlieb, MD, explains that he expects patient-centered care to be driven by payment reform. Because it is difficult to establish measures for evaluating quality of care and outcomes, Dr Gottlieb suggests that patient surveys and discussions with patients about their experiences in the healthcare setting may help link payment to performance.
As the panelists discuss their expectations regarding patient-centered care’s future role in oncology, Ted Okon, MBA, explains that it will be important to focus not only on the physician but on the entire care team, as well as on the patient. Mr Okon notes that although the physician is key to directing care, the patient should be at the center of the processes of the practice. This can help the entire healthcare practice converge on the needs of the patient.
Michael Kolodziej, MD, and Dr Gottlieb expect that as the patient-centered care model continues to evolve, it will have a positive influence on patient experiences and outcomes, and on drug development.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
What We’re Reading: FDA Approves UTI Antibiotic; Ozempic, Wegovy Price Investigation; US Births Fall
April 25th 2024The FDA recently approved an antibiotic for the treatment of urinary tract infections (UTIs) in women; a Senate committee recently launched an investigation into the prices of Novo Nordisk’s diabetes and weight loss drugs; US births fell last year, resuming a national slide after a previous increase during the pandemic.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen